SFP
ALXN

Shepherd Financial Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Shepherd Financial Partners’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,626
Closed -$514K – 116
2017
Q3 		$514K Buy
+3,626
New +$514K 0.12% 81